Tag Archives: Could

This New Covid Vaccine Could Bring Hope to the Unvaccinated World

The Coronavirus Outbreak liveLatest Updates Maps and Cases Vaccine Rollout Second Dose Outdoor Mask Guidance Advertisement Continue reading the main story Supported by Continue reading the main story Matter This New Covid Vaccine Could Bring Hope to the Unvaccinated World The German company CureVac hopes its RNA vaccine will rival those made by Moderna and… Read More »

Canada didn’t need to lose 22,000 to COVID. Here’s what could have saved them

Breadcrumb Trail Links News Health Canada This month marks a full year since Canada saw its first major lockdowns as a result of the COVID-19 pandemic. Here’s what we should have done differently Author of the article: Tristin Hopper Publishing date: Mar 10, 2021  •  5 days ago  •  3 minute read  •  213 Comments Article… Read More »

US HIV infections could drop by 94% before 2030, if treatment is prioritised

Modelling estimates suggest that new HIV infections in the US could be reduced by as much as 94% before 2030, if the current HIV prevention budget is spent more efficiently. Priorities would be linking those diagnosed with HIV to care, ensuring that they receive treatment and getting them to the point of viral suppression. Less… Read More »

Could Mom’s Thyroid Levels Influence ADHD in Kids?

By Serena Gordon HealthDay Reporter WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Low levels of thyroid hormone during pregnancy may contribute to the development of attention deficit hyperactivity disorder in the child, new research suggests. The study found that children born to mothers with low thyroid hormone levels during the first trimester of pregnancy had… Read More »

Pfizer coronavirus vaccine could be given to Americans before end of the year, CEO says

Albert Bourla, Pfizer Gian Ehrenzeller | Keystone | AP Pfizer‘s coronavirus vaccine could be distributed to Americans before the end of the year if found to be safe and effective, CEO Albert Bourla said Sunday.  The drugmaker should have key data from its late-stage trial for the Food and Drug Administration by the end of October, Bourla said… Read More »